Why SK Hynix (ADR) (SKHY) fell 3.22%
SK Hynix (ADR) (SKHY) fell 3.22% on August 28, 2026 — Korea Tech selloff hits semiconductor names.
What happened
SK Hynix ADR is falling with the Korea Tech selloff, compounded by Samsung Biologics' W3 trillion rights offering — a group-wide retreat signaling broader caution on Korean tech valuations and capital deployment risk.
Why it moved
The rights offering from Samsung Biologics adds to sentiment pressure on Korean conglomerates; combined with HBM supply normalization and AI memory premium fatigue, investors are rotating out of the entire Korea Tech…
Why it matters
Korea Tech rode AI-driven semiconductor demand and supply scarcity higher, but the theme is now reversing on valuation exhaustion and competitive supply relief.
What would break the thesis
If HBM pricing deteriorates sharply, additional Korean companies announce dilutive capital raises, or geopolitical constraints ease further (reducing supply scarcity premium), the Korea Tech selloff will deepen.
Sources
- Samsung Biologics to raise W3tr via rights offering — Korea Herald
- SK hynix recognizes new union as pay talks return to table — Korea Herald
- Why YMTC’s NAND rise matters for Samsung, SK hynix — Korea Herald